Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$494K Hold
1,365
0.23% 49
2026
Q1
$480K Hold
1,365
0.27% 44
2025
Q4
$447K Hold
1,365
0.25% 43
2025
Q3
$385K Sell
1,365
-83
-6% -$24.1K 0.24% 45
2025
Q2
$404K Buy
1,448
+83
+6% +$23.5K 0.28% 50
2025
Q1
$425K Buy
1,365
+163
+14% +$48.1K 0.35% 49
2024
Q4
$313K Sell
1,202
-7
-0.6% -$2.08K 0.23% 55
2024
Q3
$390K Hold
1,209
0.29% 52
2024
Q2
$378K Buy
1,209
+21
+2% +$6.17K 0.3% 52
2024
Q1
$338K Hold
1,188
0.28% 59
2023
Q4
$342K Buy
+1,188
New +$324K 0.31% 58

Other funds holding AMGN

Gerber LLC's AMGN Position: Q2 2026 in Review

Gerber LLC held its Amgen (AMGN) position steady in Q2 2026 at 1,365 shares worth $494K. The position accounts for 0.23% of the portfolio, ranked #49.

Gerber LLC first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,709 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gerber LLC held 1,365 shares of Amgen worth $494K as of Q2 2026.
  • Gerber LLC left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.23% of Gerber LLC's portfolio in Q2 2026, its #49 holding.
  • Gerber LLC first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,709 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gerber LLC's 13F filing for Q2 2026, filed 29 Jul 2026.